The $1 trillion private credit book that just failed its easiest test. Standalone private credit analysis — Wednesday, August 12, 2026. All prices as of ~12:15 p.m. ET.
July CPI came in exactly as hoped — +0.1% headline, +0.2% core, September hike odds cut to 42%. The S&P opened at a record. And every single private credit name on the tape is red.
Apollo −2.34%. Ares −2.03%. Blackstone −1.66%. KKR −1.66%. Blue Owl −1.62%. Brookfield −1.68%. Thirteen of the fifteen BDCs I priced are lower. Meanwhile XLK is +1.56%, KRE is +0.68%, HYG is +0.18% and gold is +1.19%.
Rate relief is the one thing the private credit bull case actually needed. It arrived this morning, and the group sold it. That is not a rates problem. That is the market telling you the asset has been re-classified — from a duration instrument into a credit instrument whose marks nobody believes.
For eighteen months the standard defence of private credit has been mechanical: these are floating-rate loans, the problem is that SOFR above 4% crushed middle-market interest coverage, and the fix is lower short rates. Every sell-side deck says some version of it.
This morning the market got the first clean instalment of that fix. Per the BLS release, headline CPI rose 0.1% m/m to 3.4% y/y and core rose 0.2% m/m to 2.5% y/y — both a tenth lower than June, both exactly in line. Treasury yields fell across the board. CME FedWatch cut September hike odds to 42%. Morgan Stanley's Ellen Zentner: "In-line inflation will keep the 'no need to hike rates' narrative intact."
Here is what each asset class did with that information:
| Asset | Last | Chg % | What it is saying |
|---|---|---|---|
| QQQ / XLK | 723.27 / 189.00 | +0.67 / +1.56 | Lower discount rate = buy long duration growth |
| KRE (regional banks) | 77.33 | +0.68 | No credit fear in bank equity |
| HYG / JNK (public HY) | 79.65 / 95.90 | +0.18 / +0.22 | Liquid credit spreads: nothing wrong |
| LQD / TLT | 106.24 / 82.31 | +0.24 / +0.15 | Duration bid, orderly |
| GLD | 405.75 | +1.19 | Real-rate relief, still the regime hedge |
| VIXY | 18.99 | −1.61 | Binary resolved, hedges bleeding |
| APO / ARES / OWL | 137.00 / 140.20 / 12.12 | −2.34 / −2.03 / −1.62 | Sold the good news |
| BX / KKR / BAM | 144.73 / 109.13 / 54.43 | −1.66 / −1.66 / −1.68 | Sold the good news |
| BIZD (BDC ETF) | 13.30 | −0.45 | Broad, not idiosyncratic |
Public credit is fine. Bank credit is fine. Only the vehicles that hold privately marked credit are down. Two days ago these same six alt managers were the best-performing group in the entire market, up 6–7% on the Nvidia $500 billion compute-financing headline. They have now given all of it back inside 48 hours while the index made a new high.
Seven days ago, on August 5, three economists at the Federal Reserve Bank of Boston published Current Policy Perspectives 26-6, "Early Warning Signals in Private Credit? What BDC Portfolios Reveal about Emerging Risks" (Fillat, Shen and Wang; full PDF here). It got essentially no press. It is the single best dataset in existence on this asset class, because BDCs are the only private credit vehicles legally required to publish a complete Schedule of Investments.
The authors harmonised 168 BDCs and roughly 890,000 company-quarter loan observations from 10-Q and 10-K filings. Read the sections on PIK usage, on spreads, and on fair-value ratios. Four findings matter:
| Finding | The number | Why it matters |
|---|---|---|
| PIK usage | ~6% of BDC loans (early 2022) → ~10% (early 2026), a 67% increase | Borrowers capitalising interest instead of paying cash. Spread across nearly every industry — construction went from <5% to ~20% — so it is not a mix effect from adding growth companies. It is broad-based cash-flow stress. |
| Spreads | Median 4–5pp over SOFR, compressed ~1pp in two years (banks charge ~2pp on comparable HY term loans) | Lenders are accepting less compensation while credit metrics soften. The Fed authors call this "a puzzle" and float two explanations: implicit restructuring, or competition eroding standards. |
| Fair value / cost | Ratio "remained relatively stable near 1.0" across the whole sample period | The industry still marks its loan book at roughly par while PIK rises 67% and spreads compress. This is the crux. |
| Marks predict returns | A 1-standard-deviation lower fair-value ratio → ~−50bp abnormal equity return the following quarter | The disclosed marks contain real, tradable information. This is a screenable factor, not a narrative. |
Two further items from the paper that go straight into the trade:
Take the Boston Fed's industry mark of ~100 cents on cost and hold it next to an actual filing. FS KKR Capital (FSK) is the second-largest listed BDC. Its Q2 2026 release and balance sheet (filed August 6) disclose the following, and the derived figures are mine:
| Metric | Reported | Derived / consequence |
|---|---|---|
| Portfolio at fair value | $11,418M | FSK marks its book at 90.6% of cost — about 9.4 points below the Boston Fed's industry median of ~1.0. |
| Portfolio at amortized cost | $12,605M | |
| Non-accruals, % of fair value | 3.8% | Implied mark on the non-accrual bucket: 48.5 cents on the dollar. $895M of cost carried at $434M. The company leads with 3.8%; the honest number is 7.1%. |
| Non-accruals, % of amortized cost | 7.1% | |
| NAV per share | $18.30 | From $18.83 (3/31) and $20.89 (12/31/25). −12.4% in six months. |
| Share price (today) | $12.16 | 33.6% discount to the company's own NAV. |
| PIK interest income, Q2 | $42M | Of $290M total investment income. 14.5% of revenue is non-cash. Cash interest is only 60.3% of revenue. |
| Incentive fee waiver | $11M | NII was $122M with the waiver. Without it: $111M = $0.397/sh. The Q3 distribution is $0.44. Ex-waiver coverage is 90.2%. |
| Purchases vs. sales/repayments | $590M vs $1,334M | Portfolio shrank 6.9% in one quarter, 12.2% year-to-date. FSK is liquidating to fund distributions. |
| Accumulated deficit | −$4,077M | Against $9,195M of capital in excess of par. 44.3% of contributed capital destroyed. |
So there are three marks on the same pool of middle-market loans. The industry says ~100 cents. FSK's own valuation committee says 90.6 cents. The public equity market says 66.4 cents. End to end, that is a 34-point spread on an asset class that is supposed to be senior secured.
One of those three numbers is going to move a very long way. It will not be the one set by people whose fees are calculated off it.
Buried in the same release: a KKR subsidiary completed a $150M tender for FSK common, FSK issued $150M of convertible preferred to a KKR subsidiary (6,000,000 shares, $25 liquidation preference), and FSK began a $300M buyback, purchasing 3,726,153 shares at a weighted average of $10.73.
Do the arithmetic the release does not do for you. The Q3 preferred dividend of $0.315972 annualises to $1.2639 on $25 — a 5.06% coupon, cheaper than FSK's own 5.49% weighted average cost of debt, while the common yields 14.4%. And the buyback, executed 41% below NAV, adds roughly $0.10/share of NAV accretion — against $0.53/share of markdowns in the same quarter. The manager is genuinely subsidising this vehicle. It is losing the race 5-to-1.
The consensus fear is "private credit blows up the banks." That fear is quantitatively wrong, and it is costing people money in the wrong short.
The Boston Fed sizes it precisely: total committed bank credit to BDCs grew from ~$10B in 2013 to more than $50B by 2025, with ~$35B drawn. That is less than 2% of large-bank Tier 1 capital, and the claims are predominantly senior secured — banks are first in line. The authors' conclusion is unambiguous: losses in a severe stress scenario "would not be large enough to threaten bank solvency," and "the direct transmission of private credit stress to banking-system stability seems to be limited."
The tape agrees. KRE was +0.68% today while APO was −2.34%. If this were a bank-contagion story those two numbers would have the same sign.
The real transmission runs through three channels nobody is short:
Fitch's July 7 note is titled, plainly, "Elevated Redemptions Persist for Perpetually Non-Traded BDCs." The individual disclosures:
| Vehicle | Size | Q2 requests | Gate | Status |
|---|---|---|---|---|
| Blackstone BCRED | ~$79B | 10% | 5% | Capped June 4; first-ever net outflow quarter was Q1 2026 |
| Apollo Debt Solutions | ~$26B | 16.8% ($2.4B) | 5% | Capped June 23; offshore requests 12.5% vs onshore 4.3% |
| BlackRock HPS Corporate Lending | ~$26B | 9.3% ($1.2B) | 5% | Capped March |
| Ares Strategic Income Fund | ~$10.7B | 11.6% | 5% | Capped March |
| Partners Group (various) | — | — | — | Warned it may curb redemptions |
Non-traded BDCs handed back more capital than they raised in Q1 2026 — the first net-outflow quarter in the product's history. Raymond James' global head of private capital advisory, Sunaina Sinha Haldea, put it to CNBC as well as anyone has:
"We're discovering in real time that you can't offer near-daily liquidity on genuinely illiquid assets without eventually testing the plumbing, and 2026 is the year those structures get rewritten."
The counterpoint, from Oaktree's Danielle Poli on the same day, is fair and worth holding: the retail wealth channel is under a quarter of the private credit market, and institutions are adding into scarcer capital. I think she is right about the asset and wrong about the equities. The listed managers' incremental earnings growth was sold to shareholders as a wealth-channel story. That is the part that is breaking.
Fitch's U.S. Private Credit Default Rate has sat at a record 6.0% since April 2026 (May release), after a 9.2% full-year 2025 print. But the composition is the story, and it cuts both ways. On the February vintage of the series (72 borrowers, 87 default events over twelve months, component breakdown here):
The bull reading: only 14% of "defaults" are hard events. Recoveries should be far better than a 6% headline implies.
The bear reading, which I hold: 86% of the default events are the lender choosing to not call a default — extending the maturity or accepting paper instead of cash. That is the same behaviour the Boston Fed independently measures from the other direction as PIK going 6% → 10%. Two datasets, two methodologies, one conclusion: the losses are being deferred, not avoided. And the deferral is being booked as income.
Both are cheap. Only one has a book you can underwrite. Blue Owl Capital Corp (OBDC) reported Q2 on August 5:
| Metric | OBDC | FSK | Read |
|---|---|---|---|
| Price (12:15 ET) | $11.65 | $12.16 | — |
| NAV / share (6/30/26) | $14.26 | $18.30 | — |
| Discount to NAV | 18.3% | 33.6% | Market demands 15 extra points from FSK |
| NAV change, 6 months | −3.7% | −12.4% | FSK destroying NAV 3.3× faster |
| Adj. NII vs. dividend | $0.34 vs $0.33 = 103% | $0.43 vs $0.44 = 98%, and only 90% ex-waiver | OBDC's coverage is unsubsidised. FSK's is not. |
| Portfolio change q/q | −2.9% | −6.9% | Both shrinking; FSK twice as fast |
| Gross portfolio yield | 10.7% | 10.2% | OBDC earns more on a better book |
| Dividend yield | 10.6% | 14.4% | FSK's yield is a warning label, not a return |
| Litigation | §36(b) derivative suit | Securities class action | See below — both material |
OBDC is not clean. It cut its base dividend 16% (from $0.37 to $0.31) and its NAV has fallen four consecutive quarters ($14.89 → $14.81 → $14.41 → $14.26). Its advisor faces a Section 36(b) derivative complaint filed with the SEC alleging that Blue Owl Credit Advisors "systematically inflated the value of the fund's assets" to extract excessive advisory fees. And in February the Blue Owl BDCs sold $1.4 billion of loans to four institutions at 99.7% of par — a transaction the manager cites as validation of its marks, and which the public market rejects by 18 points of discount every single day.
FSK's own securities class action complaint (S.D.N.Y., filed July 15, 2026) notes the stock traded at a 45.9% discount to reported NAV as of March 31. That is the relevant downside reference point, not zero.
Trigger (measurable): September FOMC hike odds fall below 25% on CME FedWatch and the Q3 BDC prints show sector non-accruals down for a second consecutive quarter and the Boston Fed's PIK share stops rising. The 6.0% Fitch PCDR ticks to 5.5% or below.
Outcome: average BDC discount compresses from ~20% toward ~10%. OBDC $13.20+, BIZD +12–15%, alt managers re-rate 15–20%. The 86%-deferrals-not-defaults bull reading proves correct and recoveries surprise.
Trigger: marks grind down 1–2% per quarter; at least one more large BDC dividend cut lands in Q3 or Q4; gates stay at 5% through the October redemption window; PIK share prints above 10% in the next Boston Fed update.
Outcome: OBDC ranges $11.00–12.50. FSK drifts to $10.50–11.50. Fee-centric managers (BX, BAM) outperform balance-sheet/wealth-channel managers (APO, ARES, OWL) by 500–800bp over three months. No systemic event.
Trigger: any one of — a top-five manager marks a flagship book down more than 5% in a single quarter; a gate is extended beyond one quarter or a vehicle suspends entirely; the §36(b) case survives a motion to dismiss with damaging valuation discovery; or the Fitch PCDR breaks 7.0%.
Outcome: BIZD −15–20%. FSK to $9. OWL to $9. APO to $118. This is where the 34-point mark gap closes violently and the sequence is filings → forced sales → marks, in that order.
Entry zone: $11.20 – $11.85 (last $11.65)
Target: $13.20 (0.93× current NAV)
Invalidation: Q3 NAV prints below $13.75, or a weekly close below $10.50
Timeframe: 1–3 months
Two independent signals: (a) adjusted NII covers the dividend at 103% without a fee waiver, the only large BDC in this note where that is true; (b) the Boston Fed's fair-value factor — OBDC's NAV path (−3.7% in six months) sits in the better half of the distribution, and the paper shows that ranking predicts next-quarter abnormal returns.
Risk, quantified: a further 5% portfolio markdown takes NAV to $13.55; holding today's 18.3% discount that implies $11.07, about −5% from the middle of the entry zone. You are paid 10.6% annualised (≈2.65% per quarter) to wait. Buying back stock at 0.82× book.
Entry zone: $12.00 – $12.70 (last $12.16)
Target: $10.40
Invalidation: weekly close above $13.30; or non-accruals at amortized cost fall below 6.0% in the Q3 print; or ex-waiver NII coverage exceeds 100%
Timeframe: 1–3 months
Three independent signals: book marked 9.4 points below the industry median and non-accruals carried at 48.5 cents; the Q3 distribution is manager-subsidised (90.2% covered ex-waiver); the portfolio is shrinking 6.9% a quarter because distributions are being funded by liquidation, not by cash interest.
Risk, quantified — read this before shorting: the carry is brutal. $0.44 per quarter on $12.16 is 3.6% per quarter you pay out. There is a live $300M buyback bid that has been executing around $10.73, roughly 12% below spot, adding ~$0.10/share of NAV per quarter. And KKR has demonstrated willingness to write cheques. Net expected value: roughly +14.5% on price to target, less ~3.6% carry per quarter held, against ~9% to invalidation. If you cannot stomach the carry, express this as "do not own the 14% yield" rather than as a short.
Entry: at market, equal dollars (ratio 0.958 today)
Target: OBDC/FSK ratio to 1.18
Invalidation: ratio below 0.88
Timeframe: 1–3 months
The cleanest expression. It isolates balance-sheet quality from sector beta and from the rate path, and it nets most of the dividend carry (10.6% received vs 14.4% paid = −3.8% annualised drag, versus −14.4% on the outright short). This is the same trade as #1 and #2 for anyone who does not want directional BDC exposure into a tape that just refused to rally on good news.
Entry zone: $138 – $147 (last $144.73, −1.66% today)
Target: $172
Invalidation: weekly close below $132
Timeframe: 1–3 months
Today's decline is group beta, not BX news. Blackstone's earnings mix is the least dependent on private-credit balance sheet and BDC incentive fees of the large six, and it is a named partner on the Nvidia $500B compute-financing platform. If the thesis in this note is right, the correct portfolio shape is long the fee-collectors and short the mark-takers — not short the whole sector.
Entry zone: $12.10 – $12.90 (last $12.12)
Target: $10.00
Invalidation: daily close above $13.60, or OBDC II reopens redemptions
Timeframe: 1–3 months
Blue Owl is the purest expression of the wealth-channel fee thesis: its earnings are disproportionately perpetual non-traded BDC AUM, its flagship listed BDC has now marked down four quarters running, it halted redemptions in OBDC II in February, and its advisor is defending a §36(b) claim that its marks were inflated to generate fees.
Why speculative, not high conviction: OWL is already down roughly two-thirds from its peak. Shorting after a 66% drawdown is how you get carried out. One signal, unconfirmed. Size accordingly — quarter-size at most.
Trigger: a print below $12.40 (last $13.30, −6.8% away)
Target: $14.50
Invalidation: weekly close below $11.60
Timeframe: 1–3 months
No trigger yet. $12.40 corresponds roughly to a 25% average sector discount to NAV, a level that has historically been where institutional money stops caring about the marks and starts buying the yield.
Trigger: KRE selling off more than 5% on a private-credit headline (last $77.33, +0.68% today)
Action: buy KRE
Invalidation: a bank disclosing NBFI exposure above 5% of Tier 1 capital
Timeframe: 1–3 months
The Boston Fed's number is <2% of large-bank Tier 1, predominantly senior secured, with the explicit conclusion that stress "would not be large enough to threaten bank solvency." Any regional-bank selloff on private-credit contagion headlines is a gift until that number changes.
| Call | Set | Then | Now | Status |
|---|---|---|---|---|
| [V] Long BX $141–147, tgt $172 | 8/11 | 147.17 | 144.73 | Intact, in entry zone |
| [W] Long BAM $52.50–55.25, tgt $63 | 8/11 | 55.36 | 54.43 | Intact, back in zone |
| [X] Fade APO $145–153, tgt $128 | 8/11 | 140.28 | 137.00 | Never triggered. Direction was right — APO is −2.3% today — and we were not filled. No credit claimed. |
| [Y] Short/avoid ORCL $144–152, tgt $126 | 8/11 | 145.48 | 150.88 (+3.71%) | Losing. Inside the short zone but moving hard against us. Invalidation >$156 not hit. On the ropes. |
| [Z] Pair long OBDC / short FSK | 8/10 | 11.68 / 12.25 | 11.65 / 12.16 | Working modestly. Upgraded to HIGH CONVICTION today on the Q2 filing detail above. |
| [AA] CRWV watch — short below $84 | 8/11 | 90.32 | 107.20 (+18.7%) | Dead and correctly abandoned. Had we triggered at $84 we would be down 27%. The decision not to initiate was the trade. |
| [BB] Trim GOOGL $340–350, tgt $325 | 8/11 | 343.80 | 341.30 | Working, in zone |
| [DD] VIXY CPI hedge $19.00–19.50 | 8/11 | 19.30 | 18.99 (−1.61%) | CLOSED — LOSER. CPI printed exactly in line; the binary resolved benignly and the hedge bled. Cost ~1.6%. It was insurance, it was cheap, and it did not pay. Close it today rather than let it decay. |
Private credit is priced in three places at once and the prices are 34 points apart: the industry marks its book at roughly par, FSK marks its own book at 90.6 cents with its non-accruals at 48.5 cents, and the public equity market marks FSK at 66.4 cents. The Boston Fed's August 5 study of 890,000 BDC loan observations shows why the industry mark is not credible — PIK usage up 67% since 2022 while spreads compressed 100bp, which is lenders accepting less compensation for visibly worse cash flows — and it shows that the disclosed marks predict subsequent equity returns, making this a factor rather than a story. Today the market delivered the private credit bull case exactly what it asked for, a tame CPI and lower yields, and the entire complex sold it while tech, banks and high yield rallied. That is the market conceding this is no longer a rates problem. The trade is therefore not "short private credit" — the bank-contagion version of that short is quantitatively wrong at less than 2% of Tier 1 capital — but long the fee-collectors and the balance sheets that cover their dividends unsubsidised, short the ones being kept alive by fee waivers and liquidation. Long OBDC, long BX, short FSK. The marks will close the gap on a court calendar, not a macro one, which is precisely why it will happen later and faster than anyone is positioned for.
Primary sources
Analysis and opinions are the author's own and are clearly marked as such throughout. Nothing here is personalised investment advice. Positions described may be held. Price data captured intraday on August 12, 2026.